171 related articles for article (PubMed ID: 23525448)
1. Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans.
Japp AG; Chelliah R; Tattersall L; Lang NN; Meng X; Weisel K; Katz A; Burt D; Fox KA; Feuerstein GZ; Connolly TM; Newby DE
J Am Heart Assoc; 2013 Jan; 2(1):e006007. PubMed ID: 23525448
[TBL] [Abstract][Full Text] [Related]
2. A thought experiment in contemporary drug development: informed bench-to-bedside strategies.
Becker RC
J Am Heart Assoc; 2013 Feb; 2(1):e000031. PubMed ID: 23525416
[No Abstract] [Full Text] [Related]
3. PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.
Wilson SJ; Ismat FA; Wang Z; Cerra M; Narayan H; Raftis J; Gray TJ; Connell S; Garonzik S; Ma X; Yang J; Newby DE
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):448-456. PubMed ID: 29269513
[TBL] [Abstract][Full Text] [Related]
4. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
[TBL] [Abstract][Full Text] [Related]
5. Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.
Maugeri N; Di Fabio G; Barbanti M; de Gaetano G; Donati MB; Cerletti C
Thromb Haemost; 2007 Jun; 97(6):965-73. PubMed ID: 17549299
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
7. Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation.
Badrnya S; Schrottmaier WC; Kral JB; Yaiw KC; Volf I; Schabbauer G; Söderberg-Nauclér C; Assinger A
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):571-80. PubMed ID: 24371083
[TBL] [Abstract][Full Text] [Related]
8. Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans.
Wacker J; Lucchinetti E; Jamnicki M; Aguirre J; Härter L; Keel M; Zaugg M
Anesth Analg; 2008 Jun; 106(6):1749-58. PubMed ID: 18499605
[TBL] [Abstract][Full Text] [Related]
9. P-selectin antagonism reduces thrombus formation in humans.
Chelliah R; Lucking AJ; Tattersall L; Daga S; Beresford-Cleary NJ; Cortas K; Fox KA; Feuerstein GZ; Connolly TM; Newby DE
J Thromb Haemost; 2009 Nov; 7(11):1915-9. PubMed ID: 19691482
[TBL] [Abstract][Full Text] [Related]
10. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes.
Passacquale G; Vamadevan P; Pereira L; Hamid C; Corrigall V; Ferro A
PLoS One; 2011; 6(10):e25595. PubMed ID: 22022418
[TBL] [Abstract][Full Text] [Related]
11. Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis.
Wilson SJ; Connolly TM; Peters G; Ghosh A; Johnson M; Newby DE
Cardiovasc Res; 2019 Mar; 115(3):669-677. PubMed ID: 30184110
[TBL] [Abstract][Full Text] [Related]
12. Measurement of monocyte-platelet aggregates by imaging flow cytometry.
Hui H; Fuller K; Erber WN; Linden MD
Cytometry A; 2015 Mar; 87(3):273-8. PubMed ID: 25514846
[TBL] [Abstract][Full Text] [Related]
13. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction.
Michelson AD; Barnard MR; Krueger LA; Valeri CR; Furman MI
Circulation; 2001 Sep; 104(13):1533-7. PubMed ID: 11571248
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase III inhibition affects platelet-monocyte aggregate formation depending on the axis of stimulation.
Horn NA; Anastase DM; Hecker KE; Baumert JH; Scheffer GJ; Rossaint R
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):162-6. PubMed ID: 16616654
[TBL] [Abstract][Full Text] [Related]
15. Impact of variables of the P-selectin - P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease.
Gremmel T; Koppensteiner R; Kaider A; Eichelberger B; Mannhalter C; Panzer S
Thromb Haemost; 2015 Apr; 113(4):806-12. PubMed ID: 25428141
[TBL] [Abstract][Full Text] [Related]
16. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
[TBL] [Abstract][Full Text] [Related]
17. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse.
Totani L; Dell'Elba G; Martelli N; Di Santo A; Piccoli A; Amore C; Evangelista V
Thromb Haemost; 2012 Jun; 107(6):1130-40. PubMed ID: 22436970
[TBL] [Abstract][Full Text] [Related]
18. Prasugrel reduces agonists' inducible platelet activation and leukocyte-platelet interaction more efficiently than clopidogrel.
Gremmel T; Eslam RB; Koppensteiner R; Lang IM; Panzer S
Cardiovasc Ther; 2013 Oct; 31(5):e40-5. PubMed ID: 23311679
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin does not lower in vivo platelet activation in healthy smokers.
Pernerstorfer T; Stohlawetz P; Stummvoll G; Kapiotis S; Szekeres T; Eichler HG; Jilma B
Br J Haematol; 1998 Sep; 102(5):1229-31. PubMed ID: 9753050
[TBL] [Abstract][Full Text] [Related]
20. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease.
Braun OO; Johnell M; Varenhorst C; James S; Brandt JT; Jakubowski JA; Winters KJ; Wallentin L; Erlinge D; Siegbahn A
Thromb Haemost; 2008 Oct; 100(4):626-33. PubMed ID: 18841285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
